title: Roflumilast, indacaterol maleate, and abiraterone acetate.
authors: College of Pharmacy, University of the Sciences in Philadelphia, USA.
authors: Daniel A
authors: DA
authors: Hussar
authors: Jeanine
authors: J
authors: DePasquale
mesh_terms: D000069501:Abiraterone Acetate; D058666:Adrenergic beta-2 Receptor Agonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000631:Aminopyridines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000730:Androstadienes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003521:Cyclopropanes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D058988:Phosphodiesterase 4 Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D015363:Quinolones / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D000631:Aminopyridines; D000730:Androstadienes; D000970:Antineoplastic Agents; D001549:Benzamides; D003521:Cyclopropanes; D007189:Indans; D058988:Phosphodiesterase 4 Inhibitors; D015363:Quinolones; C424423:Roflumilast; C510790:indacaterol; D000069501:Abiraterone Acetate